Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract 614: CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

Javier Glez-Vaz, Arantza Azpilikueta, Maria Carmen Ochoa, Irene Olivera, Gabriel Gomis, Asunta Cirella, Carlos Luri-Rey, Maite Álvarez, Sergio Ciordia, Pedro Berraondo, Álvaro Teijeira, Fernando Corrales, Juan M Zapata, Ignacio Melero

Cancer Res (2023) 83 (7_Supplement): 614.

https://doi.org/10.1158/1538-7445.AM2023-614

Published: 04 April 2023

View articletitled, Abstract 614: CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

Journal Articles

Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

Alvaro Teijeira, Saray Garasa, Carlos Luri-Rey, Carlos de Andrea, Maria Gato, Carmen Molina, Tsuneyasu Kaisho, Assunta Cirella, Arantza Azpilikueta, Steffanie K. Wculek, Josune Egea, Irene Olivera, Inmaculada Rodriguez, Ana Rouzaut, Vladislav Verkhusha, Karmele Valencia, David Sancho, Pedro Berraondo, Ignacio Melero

Cancer Res (2022) 82 (23): 4373–4385.

https://doi.org/10.1158/0008-5472.CAN-22-1046

Published: 02 December 2022

View articletitled, Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

Includes: Multimedia, Supplementary data

Journal Articles

Abstract 3826: A therapeutically actionable pro-tumoral axis of cytokines involving interleukin-8, TNFα and IL-1β

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberria, Assunta Cirella, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F. Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, Maria C. Ochoa, Carlos E. De Andrea, Pedro Berraondo, Álvaro Teijeira, Ignacio Melero

Cancer Res (2022) 82 (12_Supplement): 3826.

https://doi.org/10.1158/1538-7445.AM2022-3826

Published: 15 June 2022

View articletitled, Abstract 3826: A therapeutically actionable pro-tumoral axis of cytokines involving interleukin-8, TNFα and IL-1β

Journal Articles

Abstract 628: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies

Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, Assunta Cirella, Álvaro Teijeira, Carmen Ochoa, Maite Álvarez, Iñaki Eguren, Carlos Luri-Rey, Miguel F. Sanmamed, Ignacio Melero

Cancer Res (2022) 82 (12_Supplement): 628.

https://doi.org/10.1158/1538-7445.AM2022-628

Published: 15 June 2022

View articletitled, Abstract 628: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies

Journal Articles

Abstract 1691: CD137 (4-1BB) costimulation of CD8 T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, Peter Ellmark, Sara Fritzell, Gabriela Fernandez-Hoyos, Michelle Hase Nelson, Maite Alvarez, María del Carmen Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jauregui, Sandra Sanchez, Iñaki Etxeberría, María E. Rodriguez-Ruiz, Miguel F. Sanmamed, Alvaro Teijeira, Pedro Berraondo, Igancio Melero

Cancer Res (2021) 81 (13_Supplement): 1691.

https://doi.org/10.1158/1538-7445.AM2021-1691

Published: 01 July 2021

View articletitled, Abstract 1691: CD137 (4-1BB) costimulation of CD8 T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

Journal Articles

Abstract 1698: Cellular cytotoxicity is a form of immunogenic cell death

Luna Minute, Alvaro Teijeira, Alfonso Rodriguez Sánchez-Paulete, Maria del Carmen Ochoa, Maite Alvarez, Itziar Otano, Iñaki Etxeberria, Elixabet Bolaños, Arantza Azpilikueta, Saray Garasa, Noelia Casares, José Luiz Pérez-Gracia, Maria Esperanza Rodríguez-Ruiz, Pedro Berraondo, Ignacio Melero

Cancer Res (2020) 80 (16_Supplement): 1698.

https://doi.org/10.1158/1538-7445.AM2020-1698

Published: 15 August 2020

View articletitled, Abstract 1698: Cellular cytotoxicity is a form of immunogenic cell death

Journal Articles

Abstract 1474: Repurposing the yellow fever vaccine for intratumoral immunotherapy

M. Angela Aznar, Carmen Molina, Alvaro Teijeira, Arantza Azpilikueta, Saray Garasa, Alfonso R. Sanchez-Paulete, Iñaki Etxeberria, Maite Alvarez, Pedro Berraondo, Ignacio Melero

Cancer Res (2019) 79 (13_Supplement): 1474.

https://doi.org/10.1158/1538-7445.AM2019-1474

Published: 01 July 2019

View articletitled, Abstract 1474: Repurposing the yellow fever vaccine for intratumoral immunotherapy

Journal Articles

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming

Alfonso R. Sánchez-Paulete, Álvaro Teijeira, José I. Quetglas, María E. Rodríguez-Ruiz, Álvaro Sánchez-Arráez, Sara Labiano, Iñaki Etxeberria, Arantza Azpilikueta, Elixabet Bolaños, María Cristina Ballesteros-Briones, Noelia Casares, Sergio A. Quezada, Pedro Berraondo, David Sancho, Cristian Smerdou, Ignacio Melero

Cancer Res (2018) 78 (23): 6643–6654.

https://doi.org/10.1158/0008-5472.CAN-18-0933

Published: 03 December 2018

View articletitled, Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming

Includes: Supplementary data

Journal Articles

Abstract 639: Morphological changes in mitochondria induced by CD137 (4-1BB) co-stimulation on CD8 T cells

Sara Labiano, Álvaro Teijeira, Arantza Azpilikueta, Ángela Aznar, Elixabet Bolaños, Ignacio Melero

Cancer Res (2017) 77 (13_Supplement): 639.

https://doi.org/10.1158/1538-7445.AM2017-639

Published: 01 July 2017

View articletitled, Abstract 639: Morphological changes in mitochondria induced by CD137 (4-1BB) co-stimulation on CD8 T cells

Journal Articles

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

María E. Rodriguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, Benigno Barbes, Jose Luis Solorzano, Jose Luis Perez-Gracia, Sara Labiano, Miguel F. Sanmamed, Arantza Azpilikueta, Elixabet Bolaños, Alfonso R. Sanchez-Paulete, M. Angela Aznar, Ana Rouzaut, Kurt A. Schalper, Maria Jure-Kunkel, Ignacio Melero

Cancer Res (2016) 76 (20): 5994–6005.

https://doi.org/10.1158/0008-5472.CAN-16-0549

Published: 13 October 2016

View articletitled, Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

Includes: Supplementary data

Journal Articles

Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Alfonso R. Sánchez-Paulete, Francisco J. Cueto, María Martínez-López, Sara Labiano, Aizea Morales-Kastresana, Maria E. Rodríguez-Ruiz, Maria Jure-Kunkel, Arantza Azpilikueta, José I. Quetglas, David Sancho, Ignacio Melero

Cancer Res (2016) 76 (14_Supplement): 4908.

https://doi.org/10.1158/1538-7445.AM2016-4908

Published: 15 July 2016

View articletitled, Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Journal Articles

Abstract 4012: Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

MariaE. Rodríguez-Ruiz, Inmaculada Rodriguez, Saray Garasa, Benigno Barbes, Jose Luis Solorzano, Jose Luis Perez Gracia, Sara Labiano, Arantza Azpilikueta, Elixabet Bolanos, Alfonso R. Sanchez-Paulete, M. Angela Aznar, Ana Rouzaut, Maria Jure-Kunkel, Iñaki Etxeberria, Carlos Alfaro, Carmen Oñate, Mariano Ponz, Ignacio Melero

Cancer Res (2016) 76 (14_Supplement): 4012.

https://doi.org/10.1158/1538-7445.AM2016-4012

Published: 15 July 2016

View articletitled, Abstract 4012: Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

Journal Articles

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2^−/−IL2Rγ^null Immunodeficient Mice

Miguel F. Sanmamed, Inmaculada Rodriguez, Kurt A. Schalper, Carmen Oñate, Arantza Azpilikueta, Maria E. Rodriguez-Ruiz, Aizea Morales-Kastresana, Sara Labiano, Jose L. Pérez-Gracia, Salvador Martín-Algarra, Carlos Alfaro, Guillermo Mazzolini, Francesca Sarno, Manuel Hidalgo, Alan J. Korman, Maria Jure-Kunkel, Ignacio Melero

Cancer Res (2015) 75 (17): 3466–3478.

https://doi.org/10.1158/0008-5472.CAN-14-3510

Published: 31 August 2015

View articletitled, Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2−/−IL2Rγnull Immunodeficient Mice

Includes: Supplementary data

Journal Articles

Abstract 261: Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

Miguel F. Sanmamed, Inmaculada Rodriguez, Carmen Oñate, Arantza Azpilikueta, Maria E. Rodriguez-Ruiz, Aizea Morales-Kastresana, Sara Labiano, Jose L. Perez-Gracia, Salvador Martín-Algarra, Carlos Alfaro, Kurt A. Schalper, Guillermo Mazzolini, Francesca Sarno, Manuel Hidalgo, Alan J. Korman, Maria Jure-Kunkel, Ignacio Melero

Cancer Res (2015) 75 (15_Supplement): 261.

https://doi.org/10.1158/1538-7445.AM2015-261

Published: 01 August 2015

View articletitled, Abstract 261: Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

Journal Articles

Abstract LB-330: Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma.

Aizea Morales-Kastresana, Miguel F. Sanmamed, Inmaculada Rodriguez, Asis Palazon, Ivan Martinez-Forero, Sara Labiano, Sandra Hervas-Stubbs, Bruno Sangro, Carmen Ochoa, Arantza Azpilikueta, Elixabet Bolaños, Ines Gütgemann, Ignacio Melero

Cancer Res (2013) 73 (8_Supplement): LB-330.

https://doi.org/10.1158/1538-7445.AM2013-LB-330

Published: 15 April 2013

View articletitled, Abstract LB-330: Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma.

Journal Articles

Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein

Maria C. Ochoa, Jessica Fioravanti, Inmaculada Rodriguez, Sandra Hervas-Stubbs, Arantza Azpilikueta, Guillermo Mazzolini, Alfonso Gúrpide, Jesus Prieto, Julian Pardo, Pedro Berraondo, Ignacio Melero

Cancer Res (2013) 73 (1): 139–149.

https://doi.org/10.1158/0008-5472.CAN-12-2660

Published: 02 January 2013

View articletitled, Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein

Includes: Supplementary data

Journal Articles

Abstract #2413: Intratumoral injection of interferon-\#945; and systemic delivery of agonist anti-CD137 mAb synergize for immunotherapy in mice bearing multiple tumor lesions.

Juan Dubrot, Asis Palazon, Carmen Ochoa, Carlos Alfaro, Arantza Azpilikueta, Natalia Suarez, Ana Rouzaut, Ivan Marinez Forero, Jose L. Perez-Gracia, Aganes Le Bon, Sandra Hervas-Stubbs, Ignacio Melero

Cancer Res (2009) 69 (9_Supplement): 2413.

Published: 01 May 2009

View articletitled, Abstract #2413: Intratumoral injection of interferon-\#945; and systemic delivery of agonist anti-CD137 mAb synergize for immunotherapy in mice bearing multiple tumor lesions.

Journal Articles

The combined actins of NK and T lymphocytes are necessary to reject a transplantable mesenchymal tumor through mechanisms partly dependent on KG2D

Ainhoa Arina, Eduardo Huarte, Oihana Murillo, Iñigo Tirapu, Arantza Azpilikueta, Carlos Alfaro, Jose L. Perez-Gracia, David H. Raulet, Ignacio Melero

Cancer Res (2006) 66 (8_Supplement): 147.

Published: 15 April 2006

View articletitled, The combined actins of NK and T lymphocytes are necessary to reject a transplantable mesenchymal tumor through mechanisms partly dependent on KG2D

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 614: CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

Abstract 3826: A therapeutically actionable pro-tumoral axis of cytokines involving interleukin-8, TNFα and IL-1β

Abstract 628: Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies

Abstract 1691: CD137 (4-1BB) costimulation of CD8 T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation

Abstract 1698: Cellular cytotoxicity is a form of immunogenic cell death

Abstract 1474: Repurposing the yellow fever vaccine for intratumoral immunotherapy

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming

Abstract 639: Morphological changes in mitochondria induced by CD137 (4-1BB) co-stimulation on CD8 T cells

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Abstract 4012: Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

Nivolumab and Urelumab Enhance Antitumor Activity of Human T Lymphocytes Engrafted in Rag2^−/−IL2Rγ^null Immunodeficient Mice

Abstract 261: Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice

Abstract LB-330: Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma.

Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein

Abstract #2413: Intratumoral injection of interferon-\#945; and systemic delivery of agonist anti-CD137 mAb synergize for immunotherapy in mice bearing multiple tumor lesions.

The combined actins of NK and T lymphocytes are necessary to reject a transplantable mesenchymal tumor through mechanisms partly dependent on KG2D

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only